Objective: Intravenous thrombolysis and endovascular therapy (IVT/EVT) are evidence-based treatments for adults with arterial ischemic stroke (AIS). However, randomized controlled trials in pediatric patients are lacking. This study aimed to describe feasibility, safety, and outcome of IVT/EVT in children with AIS. Methods: This retrospective study (01/2000-12/2015) included a multicenter, population-based consecutive cohort of patients aged 1 month to 16 years, diagnosed with AIS and presenting with pediatric National Institutes of Health Stroke Scale (pedNIHSS) 4. Clinical and radiological data of patients receiving IVT/EVT were compared to those receiving standard care (SC) using linear regression to adjust for potential confounders. EVT included intra-arterial thrombolysis and/or mechanical thrombectomy. Outcome was assessed 6 months after stroke using the pediatric stroke outcome measure (PSOM). Results: Overall, 150 patients (age 7.1 6 4.9 years, 55 [37%] females) presented with pedNIHSS 4. Recanalization treatment was performed in 16 (11%), of whom 5 (3%) were treated with IVT and 11 (7%) with EVT. Patients receiving recanalization treatment were older (mean age 5 11.0 vs 6.9 years, p 5 0.01) and more severely affected (median pedNIHSS 5 13.5 vs 8.0, p < 0.001). Death and bleeding complications did not differ between the 2 groups. Median (interquartile range) PSOM 6 months after AIS was 2.5 (1-4.3) and 1 (0-2) in the IVT/EVT and SC groups, respectively (p 5 0.014). However, after multiple linear regression analysis, only higher baseline pedNIHSS remained associated with an unfavorable outcome (p < 0.001). Interpretation: Recanalization treatment is feasible and seems to be safe in severely affected pediatric AIS patients. The assessment of efficacy of IVT/EVT in pediatric stroke patients requires larger studies.
C hildhood arterial ischemic stroke (AIS) is a devastating disease affecting approximately 2-5:100,000 children per year. It is associated with significant morbidity and mortality and carries a high socioeconomic burden. [1] [2] [3] For adults, there are now highly effective treatment options for acute AIS consisting of intravenous thrombolysis or endovascular therapy (EVT), that is, endovascular thrombolysis or mechanical thrombectomy (MT). In particular, intravenous thrombolysis (IVT) with alteplase has been shown to significantly reduce disability in stroke patients without increasing mortality if given up to 4.5 hours after symptom onset. 4 Recently, endovascular thrombectomy in combination with best medical therapy has been shown to be highly effective in AIS patients with a large vessel occlusion in the anterior circulation, with a number needed to treat of 2.6.
5
In contrast to the adult population, evidence from randomized studies of recanalization treatments in children is lacking. The prospective randomized controlled trial Thrombolysis in Pediatric Stroke (TIPS) failed to recruit patients due to late arrival at hospital, diagnostic delay, and lack of established acute stroke programs. 6, 7 Further trials assessing recanalization treatment in pediatric stroke patients are unlikely, considering the clinical and ethical difficulties in randomizing pediatric stroke patients who are candidates for the treatment and also with regard to the overwhelming efficacy of these therapies in adults. 8 Stroke etiologies in children differ from those in adults, and therefore results cannot simply be extrapolated to pediatric stroke patients. Most centers agree on the use of aspirin or heparin for the treatment of acute stroke in children with AIS. The use of recanalization treatment (ie, IVT or EVT) in pediatric AIS has been reported. [9] [10] [11] [12] [13] [14] [15] However, population-based data on recanalization treatments in pediatric stoke patients are lacking. Therefore, we aimed to assess feasibility, safety, and outcome of AIS patients treated with IVT/EVT in the population-based Swiss NeuroPediatric Stroke Registry (SNPSR).
Patients and Methods

Study Design and Study Population
This is a cohort study of consecutive pediatric AIS patients included in the SNPSR. The SNPSR is a nationwide prospective registry that includes all pediatric AIS patients living in Switzerland. 1, 3 All children aged 1 month to 16 years diagnosed with AIS between 2000 and 2015 who had a pediatric National Institutes of Health Stroke Scale (pedNIHSS) score 4 at presentation were included. Patients with neonatal stroke or cerebral venous thrombosis were excluded. AIS was defined as a new focal neurological deficit with ischemic lesion visible on magnetic resonance imaging (MRI) in the corresponding vascular territory. Patients who received recanalization treatment (ie, IVT), endovascular pharmacological and/or mechanical treatment, or a combination of both-hereafter called the recanalization groupwere compared to those receiving standard care (SC).
Variables at Stroke Onset
Baseline characteristics (ie, demographic data, vascular risk factors, laboratory findings), treatment modalities, and time from symptom onset to diagnosis and treatment were recorded. Stroke severity was assessed using the pedNIHSS. Patients diagnosed before 2011 were scored for pedNIHSS retrospectively. 16, 17 All patients underwent MRI or computed tomographic imaging (CT) to rule out intracranial hemorrhage, and magnetic resonance angiography to assess the site of vessel occlusion. Intravenous and endovascular therapies for children were adapted based on international and institutional guidelines for adult stroke patients. In general, IVT was performed with either a full dose (0.9ml/kg body weight) or a two-thirds dose (0.6ml/kg body weight) of intravenous tissue plasminogen activator (tPA) within 4.5 hours after symptom onset. In patients with basilar artery occlusions, or in selected cases, extended time windows were applied based on imaging. EVT was performed if: (1) diagnosis of ischemic stroke was established, (2) baseline pedNIHSS score was 4 points, (3) hemorrhage on cranial CT or MRI was excluded, (4) vessel occlusion correlated with the neurological deficit, and (5) no individual clinical or premorbid conditions or laboratory findings contraindicated thrombolysis. 18, 19 However, the final decision on treatment was at the discretion of the neuropediatricians, neurologists, and interventional neuroradiologists on call. Digital subtraction angiography was performed via the transfemoral approach. Endovascular recanalization procedures consisted of a combination of techniques such as intra-arterial pharmacological treatment (urokinase, n 5 2; intravenous tPA, n 5 12; eptifibatide, n 5 1) or MT. Device selection depended on occlusion pattern and operator preference; mechanical recanalization was performed using thromboaspiration and stent retrievers. Immediately after IVT and/or EVT, all patients were transferred to the pediatric intensive care unit. Twenty-four hours after treatment, or earlier in the case of clinical deterioration, a CT or MRI scan was performed. Recanalization rates were classified as complete, partial, or no recanalization by the responsible neuroradiologists. Symptomatic intracerebral hemorrhage (sICH) and asymptomatic intracerebral hemorrhage (aICH) were classified according to the European Cooperative Acute Stroke Study III study protocol. 20, 21 Nonthrombolysed patients were transferred either to the pediatric intensive care unit or to the pediatric ward. They were treated, according to the discretion of the responsible neuropediatrician, mainly with aspirin and/or heparin. Etiology of stroke was assessed using the Cascade classification. 22 Complete stroke workup was defined according to the recommendations in the SNPSR and included echocardiography, MRI, and vessel imaging of head and neck as well as screening for infection, metabolic disease, coagulation pathology, and vasculitis. Complications assessed were as follows: malignant middle cerebral artery infarct (MMCAI), sICH, aICH, any bleeding, or stroke-related mortality. 19 Neuropediatricians examined all patients 6 months after stroke onset. Disability was scored using the pediatric stroke outcome measure (PSOM), in some cases retrospectively.
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Statistical Analysis
We primarily assessed feasibility, safety, and outcome of recanalization treatment in pediatric AIS patients 6 months after AIS treatment. Secondary outcomes included the PSOM at discharge and 2 years after AIS, treatment-related complications, and stroke-related mortality. Variables were summarized descriptively by treatment type for all the patients included and no imputation of missing variables was performed. Betweengroup comparisons for categorical variables were made using the chi-square or Fisher exact test, as appropriate, and for continuous variables using the Wilcoxon rank sum test. Adjustment for potential confounders was performed using a multiple linear regression model. Besides modality of treatment (recanalization treatment vs SC), variables included in the linear regression model were chosen according to the results from univariate analysis (p < 0.2). We performed 2 subgroup analyses. The first controlled for initial pedNIHSS, that is, eliminated patients in the SC group with pedNIHSS < 10. The second compared patients treated with thrombolysis (IVT and intra-arterial thrombolysis [IAT] ) to those treated with endovascular thrombectomy (use of MT). A 2-sided p value of < 0.05 was considered statistically significant. Analysis was performed using R (version 3. Table 1 . All but 1 patient (Patient 5) were diagnosed within 12 hours after symptom onset; however, 4 patients were treated > 6 hours after symptom onset. All these patients had an occlusion of the basilar artery. Three patients had a stroke due to unilateral focal cerebral arteriopathy and 4 patients due to cardioembolism. Stroke etiology remained undetermined in the remaining 9 patients. Of the latter, 3 had risk factors associated with childhood stroke (Evans syndrome with hemolysis and homozygous MTHFR mutation in Patient 6, decreased protein S in Patient 8, and elevated lipoprotein a in Patient 15). Five patients (31.2%) had a basilar artery occlusion, 7 (43.8%) a middle cerebral artery (MCA) occlusion, and 4 (25%) an internal carotid artery occlusion. Five patients (31.2%) were treated with IVT only, and 5 patients received intra-arterial pharmacological treatment with either tPA or urokinase. The remaining 6 patients were treated with MT; 1 of these patients received pretreatment with IVT, and 4 patients received additional intra-arterial pharmacological treatment. Only 1 patient was treated with MT alone.
Complications of recanalization therapy occurred in 2 patients (12.5%). One patient experienced an asymptomatic ICH and 1 mucosal bleeding. Furthermore, 5 patients developed an MMCAI requiring hemicraniectomy, and 1 of these patients died due to massive herniation. The indication for hemicraniectomy was based on evolving mass effect due to infarct growth and malignant edema over 24 to 48 hours poststroke. There was no evidence of hemorrhages or reinfarctions in these patients. The pedNIHSS of patients with MMCAI ranged between 14 and 21. Recanalization was assessed immediately after the intervention in those patients receiving endovascular treatment and within the first 24 hours in those receiving IVT. Complete recanalization at followup was seen in 4 (25%), partial in 6 (38%), and no recanalization in 4 (25%) patients. Information on recanalization rates was lacking for 2 (12%) patients. None of the patients developed a new thrombus. All patients who showed no recanalization at follow-up had been treated with IVT >6 hours after symptom onset. Median PSOM 6 months after stroke was 2.5 (IQR 5 1.0-4.3). Overall, the use of recanalization treatment increased over the years of the study (Fig 1) . The comparison of patients treated with thrombolysis (ie, IVT and IAT) and endovascular thrombectomy (ie, use of MT) did not reveal any statistically different results ( Table 2) .
Comparison of Recanalization Treatment with SC Significant differences were noted between patients who received recanalization treatment and those who did not. In univariate analysis, patients who had recanalization treatment were older (p 5 0.001), had a higher baseline pedNIHSS (p < 0.001), and had a shorter time interval from symptom onset to diagnosis (p < 0.001). However, stroke etiology and the site of vessel occlusion did not differ between the 2 groups (see Supplementary Table 1) . Overall, in univariate analyses bleeding complications did not occur significantly more frequently in patients who had recanalization treatment than in patients receiving SC, whereas MMCAI was diagnosed in 5 patients (31.2%) in the recanalization group compared to 12 (9%) in the SC group (p 5 0.012). Median PSOM at 6 months was 2.5 (IQR 5 1.0-4.3) in the recanalization and 1.0 (IQR 5 0-2.0) in the SC group (p 5 0.014; see Supplementary  Table 1 ). However, in a multiple regression analysis after adjusting for age, baseline pedNIHSS, diagnostic delay, and modality of treatment, only higher baseline ped-NIHSS was associated with a higher PSOM 6 months after stroke, but not recanalization treatment (Supplementary  Table 3 ). Eliminating the impact of initial pedNIHSS by excluding patients with initial pedNIHSS < 10 in the SC group, the PSOM 6 months after stroke no longer differed between groups (Supplementary Tables 2 and 4 ).
Discussion
Whether IVT and endovascular treatment approaches are feasible, safe, and effective in children who have had an acute ischemic stroke is currently one of the most pressing questions in pediatric stroke research. The main findings of our population-based series of consecutive pediatric AIS patients treated with various recanalization approaches were: (1) recanalization treatment is feasible, and 16 of 150 acute stroke patients with pedNIHSS 4 were treated with either IVT or EVT; (2) complications did not occur more frequently in patients who received recanalization treatment; (3) patients who received IVT and EVT had suffered a more severe stroke; (4) mortality did not differ between the 2 treatment groups; and (5) in multivariate analysis, stroke severity, as evaluated by pedNIHSS, was the only significant predictor of unfavorable outcome according to PSOM. 
Rates of Revascularization Procedures
This population-based cohort study supports the view that recanalization therapy in children is used rarely (10%); however, an increase in its use over time was noted (see Fig 1) . The most likely reasons for the low usage are lack of evidence available from randomized controlled trials, late presentation, diagnostic delay, and uncertainty regarding safety and clinical efficacy. In our cohort, one-third of patients were diagnosed >24 hours after symptom onset; thus, recanalization treatment was no longer possible. Although we observed an increase in early presentation over time, resulting in a higher proportion of pediatric AIS patients being diagnosed and treated early, there is still an urgent need to increase awareness of stroke in the pediatric population to allow more pediatric AIS patients to be evaluated for recanalization treatment (Fig 2) .
Revascularization Techniques
The use of the different revascularization techniques was performed individually according to the discretion of the interdisciplinary team on call. Performing a subgroup analysis comparing the use of thrombolysis to endovascular thrombectomy we could not show any statistically significant difference regarding recanalization rates and outcome. However, the potential impact of the technique on outcome is important and requires further attention in future studies focusing on pediatric stroke treatments.
Safety
One of the major concerns of neuropediatricians about the use of acute recanalization techniques in children relates to their safety, for example, the potential for disabling or even fatal bleeding complications. However, no severe or fatal treatment-related complications occurred in our study, which is in line with previous reports. 9, 10, 12 Rates of hemorrhagic transformations and mortality did not differ between the 2 treatment groups. Furthermore, no complications occurred during endovascular procedures. This finding is in line with those of recent reviews reporting low complication rates in children who received endovascular treatment for AIS. This is important, as stroke etiologies in children differ from adults and therefore the results of randomized controlled trials cannot simply be extrapolated to pediatric stroke patients. 26 Children more often have strokes due to an underlying arteriopathy, especially of inflammatory origin, which might increase the risk of bleeding complications during endovascular procedures, due to vessel fragility. In our cohort, we had only 1 patient with focal cerebral arteriopathy who underwent endovascular treatment, and therefore no firm conclusions regarding its influence on outcome are possible. However, vascular fragility and risk of hemorrhage need to be considered and weighted carefully against a potential benefit of a recanalization treatment in this specific patient population. Future research should include consideration of stroke etiology when assessing recanalization techniques. Four patients received IVT >4.5 hours after symptom onset, and none of these patients recanalized. No bleeding complications occurred in these patients, but they also showed no clear benefit from IVT. Therefore, in pediatric stroke patients, as in adults, the benefit of IVT >4.5 hours after stroke is questionable. 
Severity of AIS
Patients receiving IVT and EVT were more severely affected than those receiving SC (pedNIHSS 5 13.5 vs 8.0, p < 0.001). MMCAI is a serious concern in patients suffering from a large anterior circulation stroke. In our cohort, development of MMCAI occurred in 17 patients (ie, 17% of all MCA strokes) and was more frequent in patients receiving recanalization treatment than in the SC group. The frequency of MMCAI ranges between 1.3% and 18% in pediatric AIS patients and is associated with higher baseline pedNIHSS as shown in our cohort. [27] [28] [29] Therefore, the higher frequency of MMCAI in the recanalization group is likely to be an epiphenomenon of more severe infarcts, rather than a complication attributable to the treatment modality itself.
Mortality
Mortality in patients treated with recanalization techniques was not higher than in the SC group, despite higher baseline pedNIHSS. Compared to the SC group, patients receiving recanalization treatment had worse neurological outcome at discharge and 6 months poststroke (see Supplementary Table 1 ). However, after adjusting for age, baseline pedNIHSS, and diagnostic delay, treatment modality was not a predictor of unfavorable outcome. The initial severity of the stroke was the only relevant factor associated with unfavorable outcome. This finding was confirmed by a subgroup analysis controlling for initial pedNIHSS.
Outlook
Evidence from randomized trials as to whether recanalization techniques in pediatric patients are safe and clinically effective is needed. However, a previous prospective randomized controlled trial (TIPS) failed to recruit patients, and further trials assessing recanalization treatment in the pediatric stroke population are unlikely. This is because of the clinical and ethical difficulties in randomizing pediatric stroke patients against the background of overwhelming evidence for a very strong treatment effect in adults. Therefore, alternative approaches such as large international prospective treatment registries allowing for data pooling and matching are urgently needed to gain further insights into optimal treatment regimens for pediatric stroke patients. In the meantime, standardized treatment protocols and recommendations should be developed and implemented to provide guidance for neuropediatricians treating pediatric stroke patients. 7 A major strength of our study is the population-based nature of the SNPSR and the relatively large sample size. One major limitation is the inhomogeneous cohort, with anterior and posterior circulation stroke patients treated with different treatment modalities. Another is the absence of standardized protocols in the different centers. Some patients with basilar artery occlusion were thrombolysed >6 hours after symptom onset, which is not evidence based in the adult population. The small sample size, especially in the interventional treatment group, clearly restricts the statistical power of comparisons and multiple regression. Therefore, nonsignificant findings have to be interpreted with caution. Furthermore, treatment approaches have dramatically changed during the past 10 years, and given the sample size, we were not able to restrict the analysis to the past 5 years. Finally, to assess efficacy of recanalization treatment, a more homogeneous cohort, standardized assessment of recanalization status, and a matched analysis would have been valuable.
Conclusions
Recanalization treatment appears to be a feasible and safe treatment option for pediatric AIS patients. A large proportion of such patients are still diagnosed too late, missing the opportunity to be assessed for recanalization treatment options. Previous attempts have shown that a randomized controlled trial of acute stroke treatment in pediatric patients is not feasible. Therefore, larger prospective population-based registries are needed to allow for matching and data pooling to identify those patients most likely to benefit from recanalization treatment.
